2011
Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries
Darefsky AS, King JT, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries. Cancer 2011, 118: 2163-2172. PMID: 21882183, PMCID: PMC3235223, DOI: 10.1002/cncr.26494.Peer-Reviewed Original ResearchConceptsHazard ratioTemozolomide eraMultivariate-adjusted hazard ratiosEnd Results Program databaseKaplan-Meier methodPopulation-based surveillanceTwo-year survivalAge-stratified analysisConfidence intervalsPopulation-based analysisAge 20 yearsProportional hazards modelProgressive decreaseTemozolomide useOlder patientsSurgical resectionSurvival improvementTreatment advancesProgram databaseGBM patientsHazards modelGBM treatmentAge 20Age groupsGlioblastoma multiforme survival
2006
Multivariate analysis identifies factors that affect survival after stereotactic radiosurgery for brain metastases
Diluna M, King J, Knisely J, Bond J, De Lotbiniere A, Chiang V. Multivariate analysis identifies factors that affect survival after stereotactic radiosurgery for brain metastases. Journal Of Clinical Oncology 2006, 24: 11500-11500. DOI: 10.1200/jco.2006.24.18_suppl.11500.Peer-Reviewed Original ResearchCell lung carcinomaStereotactic radiosurgeryBrain metastasesCerebral metastasesSurgical resectionEsophageal cancerLung carcinomaBreast cancerNon-small cell lung carcinomaSmall cell lung carcinomaSystemic controlConnecticut Tumor RegistryLocation of metastasesNumber of metastasesPatient-related factorsTotal tumor burdenSystemic disease controlKaplan-Meier plotsSignificant independent predictorsSurvival dataTotal tumor volumeMedian survivalWorse survivalImproved survivalIndependent predictors